Valuation: PolyPeptide Group AG

Market Cap 1.65B 1.88B 1.52B 1.4B 2.66B 179B 2.7B 18.15B 7.11B 88.39B 7.05B 6.9B 304B P/E 2026 *
70.7x
P/E 2027 * 36.7x
Enterprise Value 1.75B 2B 1.61B 1.49B 2.83B 190B 2.87B 19.29B 7.56B 93.95B 7.5B 7.33B 323B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.14x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.07%
1 day-2.23%
1 week-6.88%
Current month-2.23%
1 month+36.09%
3 months+45.34%
6 months+63.41%
Current year+76.25%
1 week 45.25
Extreme 45.25
50.1
1 month 32.9
Extreme 32.9
50.1
Current year 23.1
Extreme 23.1
50.1
1 year 20.1
Extreme 20.1
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 12/04/2023
Director of Finance/CFO 54 02/01/2024
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Chairman 69 01/04/2021
Director/Board Member 62 01/01/2021
Date Insider Type Main position Quantity % Market Cap.
13/11/23Buy 2,500 0.0075%
12/10/23Buy 159,959 0.4829%
06/04/23Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-2.23%-6.88%+116.47%+164.82% 1.88B
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -1.28%-3.61%+33.61%+66.45% 357.58B
Weighted average by Cap. -1.32%-2.96%+35.32%+81.31%

Financials

2026 *2027 *
Net sales 487M 556M 449M 415M 786M 53B 799M 5.37B 2.1B 26.14B 2.09B 2.04B 89.83B 564M 643M 520M 480M 910M 61.38B 925M 6.22B 2.44B 30.27B 2.42B 2.36B 104B
Net income 23.19M 26.46M 21.39M 19.75M 37.44M 2.52B 38.05M 256M 100M 1.24B 99.33M 97.17M 4.28B 45.02M 51.38M 41.52M 38.34M 72.7M 4.9B 73.88M 496M 195M 2.42B 193M 189M 8.31B
Net Debt 104M 118M 95.53M 88.21M 167M 11.28B 170M 1.14B 448M 5.56B 444M 434M 19.11B 126M 143M 116M 107M 203M 13.67B 206M 1.38B 543M 6.74B 538M 526M 23.17B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,440
Date Price Change Volume
10/07/26 CHF 46.00 -2.23% 24,679
09/07/26 CHF 47.05 +3.98% 32,537
08/07/26 CHF 45.25 -3.72% 40,160
07/07/26 CHF 47.00 -4.76% 57,992
06/07/26 CHF 49.35 -0.10% 61,436
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
49.87EUR
Average target price
41.75EUR
Spread / Average Target
-16.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock